Seqera Labs
| Company type | Private |
|---|---|
| Industry | Bioinformatics |
| Founded | 2018 |
| Founders | Evan Floden, Paolo di Tommaso |
| Headquarters | Barcelona, Spain |
| Services | technologies for data pipelines |
| Parent | Centre for Genomic Regulation (CRG) |
Seqera Labs is a bioinformatics company developing technologies for data pipelines, founded in 2018 in Barcelona.[1] It is a spin-off of the Centre for Genomic Regulation (CRG) founded by Evan Floden and Paolo di Tommaso and its services are largely related to the open-source software Nextflow, released in 2013.[1][2][3]
In 2022, the company raised 22 million euros in Series A funding.[4] It has also received several grants from the Chan Zuckerberg Initiative.[5]
References
[edit]- ^ a b Allen, Patricia (2022-10-25). "Barcelona-based Seqera Labs secures €22 million to help power innovation in healthcare and life sciences". EU-Startups. Retrieved 2023-03-30.
- ^ Lunden, Ingrid (2021-09-07). "Seqera Labs grabs $5.5M to help sequence COVID-19 variants and other complex data problems". TechCrunch. Retrieved 2023-03-30.
- ^ Kliver, Jenny. "CRG spin-off Seqera Labs raises 22 million euros in Series A funding – Barcelona Institute of Science and Technology – BIST". Retrieved 2023-03-30.
- ^ "Addition leads Seqera Labs' €22 million investment round". Tech.eu. 2022-10-24. Retrieved 2023-03-30.
- ^ "Mark Zuckerberg-backed Seqera Labs lands €22M as follow-on investment — TFN". Tech Funding News. 2022-10-25. Retrieved 2023-03-30.